Conduit Pharmaceuticals Inc. Financial Flexibility Index
Conduit Pharmaceuticals Inc. financial flexibility index. Conduit Pharmaceuticals Inc. (CDT) has a Financial Flexibility Index of 0.04x as of June 2026. Free cash flow of $83.40 Million (operating CF $42.74 Million minus capex $40.66 Million) represents 0% of total liabilities ($2.12 Billion). See Conduit Pharmaceuticals Inc. free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Conduit Pharmaceuticals Inc. (2021–2025)
Financial flexibility index of Conduit Pharmaceuticals Inc. from 2021 to 2025. Historical Financial Flexibility Index trend for Conduit Pharmaceuticals Inc. across 5 annual periods. Check earnings quality score of Conduit Pharmaceuticals Inc. to evaluate the quality of earnings relative to operating cash generation.
Conduit Pharmaceuticals Inc. Financial Flexibility Index by Year (2021–2025)
Conduit Pharmaceuticals Inc. financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for Conduit Pharmaceuticals Inc.. For the full cash flow conversion analysis, see Conduit Pharmaceuticals Inc. cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.01x | $-13.15 Million | $-15.55 Million | $2.28 Billion | ▲ +99.3% |
| 2024 | -0.88x | $-9.63 Million | $-9.68 Million | $10.99 Million | ▲ +12.8% |
| 2023 | -1.01x | $-7.72 Million | $-7.72 Million | $7.68 Million | ▼ -348.0% |
| 2022 | -0.22x | $-2.27 Million | $-2.27 Million | $10.09 Million | ▲ +98.0% |
| 2021 | -11.17x | $-2.15 Million | $-2.15 Million | $192.51K | — |